Xiaojing Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Xiaojing Wu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Jian Sun
Tianjin Key Laboratory for Modern Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, People’s Republic of China
1 shared publication - Mingfei Han
National Center for Protein Sciences (Beijing)
1 shared publication - Song He
Academy of Military Medical Sciences
1 shared publication - Xiaochen Bo
Academy of Military Medical Sciences, Beijing 100850, China
1 shared publication - Xiaolei Song
Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China
1 shared publication - Xinyu Song
Research Center for Medical Big Data, Medical Innovation Research Division of Chinese PLA General Hospital , Beijing 100039, China
1 shared publication
Latest Publications
- Open Access
- 23 November 2023
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 39 (12)
COMMO: a web server for the identification and analysis of consensus gene modules across multiple methods
Summary: A variety of computational methods have been developed to identify functionally related gene modules from genome-wide gene expression profiles. Integrating the results of these methods to identify consensus modules is a promising approach to produce more accurate and robust results. In this application note, we introduce COMMO, the first web server to identify and analyze consensus gene functionally related gene modules from different module detection methods. First, COMMO implements eight state-of-the-art module detection methods and two consensus clustering algorithms. Second, COMMO provides users with mRNA and protein expression data for 33 cancer types from three public databases. Users can also upload their own data for module detection. Third, users can perform functional enrichment and two types of survival analyses on the observed gene modules. Finally, COMMO provides interactive, customizable visualizations and exportable results. With its extensive analysis and interactive capabilities, COMMO offers a user-friendly solution for conducting module-based precision medicine research. Availability and implementation: COMMO web is available at https://commo.ncpsb.org.cn/, with the source code available on GitHub: https://github.com/Song-xinyu/COMMO/tree/master.
- 23 November 2023
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 39 (12)
Open AccessCOMMO: a web server for the identification and analysis of consensus gene modules across multiple methods
Summary: A variety of computational methods have been developed to identify functionally related gene modules from genome-wide gene expression profiles. Integrating the results of these methods to identify consensus modules is a promising approach to produce more accurate and robust results. In this application note, we introduce COMMO, the first web server to identify and analyze consensus gene functionally related gene modules from different module detection methods. First, COMMO implements eight state-of-the-art module detection methods and two consensus clustering algorithms. Second, COMMO provides users with mRNA and protein expression data for 33 cancer types from three public databases. Users can also upload their own data for module detection. Third, users can perform functional enrichment and two types of survival analyses on the observed gene modules. Finally, COMMO provides interactive, customizable visualizations and exportable results. With its extensive analysis and interactive capabilities, COMMO offers a user-friendly solution for conducting module-based precision medicine research. Availability and implementation: COMMO web is available at https://commo.ncpsb.org.cn/, with the source code available on GitHub: https://github.com/Song-xinyu/COMMO/tree/master.
- Open Access
- 1 January 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 5504475
Subcellular Proteome Analysis Reveals Apoptotic Vulnerability of T‐Cell Acute Lymphoblastic Leukemia
Targeting death receptor‐mediated apoptosis in T‐cell acute lymphoblastic leukemia (T‐ALL), an aggressive disease with poor prognosis, is hindered by the inherent resistance of primary leukemia cells. Knowledge on therapeutic vulnerabilities in these malignant cells will provide opportunities for developing novel combinatory treatments for patients. Using label‐free quantitative mass spectrometry and subcellular fractionation techniques, we systematically compared organelle‐specific proteomes between Jurkat cells, an in vitro model for T‐ALL, and a Jurkat mutant with increased resistance to death receptor‐mediated apoptosis. By identifying several differentially regulated protein clusters, our data argued that extensive metabolic reprograming in the mitochondria, characterized by enhanced respiration and energy production, might allow cells to evade DR5‐mediated cytotoxicity. Further analysis using clinical datasets demonstrated that the elevated expression of a three‐gene signature, consisting of SDHA, IDH3A, and ANXA11, was significantly associated with poor survival of acute leukemia patients. Our analysis therefore provided a unique dataset for a mechanistic understanding of T‐ALL and for the design of novel ALL treatments.
- 1 January 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 5504475
Open AccessSubcellular Proteome Analysis Reveals Apoptotic Vulnerability of T‐Cell Acute Lymphoblastic Leukemia
Targeting death receptor‐mediated apoptosis in T‐cell acute lymphoblastic leukemia (T‐ALL), an aggressive disease with poor prognosis, is hindered by the inherent resistance of primary leukemia cells. Knowledge on therapeutic vulnerabilities in these malignant cells will provide opportunities for developing novel combinatory treatments for patients. Using label‐free quantitative mass spectrometry and subcellular fractionation techniques, we systematically compared organelle‐specific proteomes between Jurkat cells, an in vitro model for T‐ALL, and a Jurkat mutant with increased resistance to death receptor‐mediated apoptosis. By identifying several differentially regulated protein clusters, our data argued that extensive metabolic reprograming in the mitochondria, characterized by enhanced respiration and energy production, might allow cells to evade DR5‐mediated cytotoxicity. Further analysis using clinical datasets demonstrated that the elevated expression of a three‐gene signature, consisting of SDHA, IDH3A, and ANXA11, was significantly associated with poor survival of acute leukemia patients. Our analysis therefore provided a unique dataset for a mechanistic understanding of T‐ALL and for the design of novel ALL treatments.